Government of Canada
Symbol of the Government of Canada

Government of Canada

japan.gc.ca

Breadcrumb

  1. Home

Japan Session @BIO2018

Japan is home to the world’s second largest pharmaceutical market, valued at more than US$90 billion dollars.  Japanese life sciences companies are proactively seeking open innovation partners, aiming to strengthen their product pipelines to cope with international competition and address unmet medical needs.  Japanese life sciences companies and venture capitalists will be attending BIO2018 to identify international partners whose technologies and products may enhance their portfolios.

The Embassy of Canada in Japan is pleased to organize Japan Session@ BIO2018, featuring major life sciences companies in Japan. Representatives from these companies will present their strategies for in licensing and investment. We hope this will be an efficient venue for your company’s business development during BIO2018, specifically targeting Japanese companies. Looking forward to seeing you at Japan Session@ BIO2018!

Date & Time: June 4 (Mon) PM 14:00 – 15:30

Venue:
Meeting Room “Smoot” at Hotel Aloft Boston Seaport District  (Across from the Convention Center) MAP
401-403 D Street, Boston, Massachusetts / TEL: +1 (617) 530-1600

Organized by:
Global Affairs Canada
Consulate General of Canada in Boston
Embassy of Canada to Japan

Registration: To RSVP, send an email with your name, title, organization, and contact information to tokyohealth/sante@international.gc.ca  

Program

Opening Remarks
Global Affairs Canada 

Presentation 1
Dr. Masahiko Ohtsuki, Corporate Officer, Vice President, Business Development & Licensing Department, Daiichi Sankyo Co., Ltd.

Presentation 2
Mr. Yoshiaki Kato, President, KISSEI AMERICA, INC., Subsidiary of KISSEI PHARMACEUTICAL CO LTD Japan

Presentation 3
Dr. Hiroshi Kawai, Vice President, Business Development, Mitsubishi Tanabe Holdings America, Inc.

Presentation 4
Mr. Walter Olesiak, Partner, REMIGES Ventures Inc.

Footer

Date Modified:
2018-05-22